These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 1569924
1. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors. Flynn DD, Vaishnav AA, Mash DC. Mol Pharmacol; 1992 Apr; 41(4):736-42. PubMed ID: 1569924 [Abstract] [Full Text] [Related]
2. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists. Gillard M, Waelbroeck M, Christophe J. Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611 [Abstract] [Full Text] [Related]
3. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions. Lee NH, el-Fakahany EE. J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516 [Abstract] [Full Text] [Related]
4. Selectivity of class I antiarrhythmic agents, disopyramide, pirmenol, and pentisomide for peripheral muscarinic M2 and M3 receptors. Endou M, Hattori Y, Gando S, Kanno M. J Cardiovasc Pharmacol; 1992 May; 19(5):674-81. PubMed ID: 1381764 [Abstract] [Full Text] [Related]
5. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists. Fisher SK. Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485 [Abstract] [Full Text] [Related]
6. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors. Potter LT, Ferrendelli CA, Hanchett HE, Hollifield MA, Lorenzi MV. Mol Pharmacol; 1989 May; 35(5):652-60. PubMed ID: 2725474 [Abstract] [Full Text] [Related]
7. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors. Tucek S, Musílková J, Nedoma J, Proska J, Shelkovnikov S, Vorlícek J. Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700 [Abstract] [Full Text] [Related]
8. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands. Hu J, Wang SZ, Forray C, el-Fakahany EE. Mol Pharmacol; 1992 Aug; 42(2):311-21. PubMed ID: 1513329 [Abstract] [Full Text] [Related]
9. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain. Flynn DD, Mash DC. Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852 [Abstract] [Full Text] [Related]
10. Evidence of paired M2 muscarinic receptors. Potter LT, Ballesteros LA, Bichajian LH, Ferrendelli CA, Fisher A, Hanchett HE, Zhang R. Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905 [Abstract] [Full Text] [Related]
11. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain. Norman AB, Eubanks JH, Creese I. J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964 [Abstract] [Full Text] [Related]
12. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex. Ehlert FJ, Jenden DJ. Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562 [Abstract] [Full Text] [Related]